Questions Sent to FDA and ABR on Humanized Mice Contract
CNS News -

On July 17, 2018, sent the following questions to the Food and Drug Administration and Advanced Bioscience Resources about the contract cited in the FDA’s June 13 presolicitation notice:

1-Has the FDA finalized this contract with Advanced Bioscience Resources to acquire fresh “human fetal tissue” from aborted babies for “implantation into severely immune-compromised mice”?



Related Articles